Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07447206 · ClinicalTrials.gov registry record · Phase 2
Vascular Intervention Strategies Trial for Alzheimer's
A Phase 2 study, sponsored by University of Southern California.
- Not yet
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT07447206: Clinical Trial Phase 2 study, sponsored by University of Southern California.
NCT07447206 is a Phase 2 study that has not yet begun recruiting, run by University of Southern California. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07447206, a Phase 2 study, has not yet begun recruiting, sponsored by University of Southern California.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The proposed pharmacist-led study is a feasibility pilot trial for the management of vascular risk factors of hypertension and hypercholesterolemia in 10 APOE ε4 carriers, 50-75, at-risk for dementia. All participants will receive angiotensin receptor blockers (ARBs) for high blood pressure, and hydrophilic statins (or a non-statin alternative) for high cholesterol over a six-month period.
Primary Outcome
Change in systolic blood pressure (mmHg) from baseline to the end of the 6-month intervention.
Interventions
- DRUG Angiotensin Receptor Blockers (ARBs)
- DRUG Hydrophilic Statins or Non-Statin Alternative
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-05 |
| Est. Completion | 2028-06 |
| Phase | Phase 2 |
What is known before NCT07447206 opens enrollment
NCT07447206 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Angiotensin Receptor Blockers (ARBs) is the first listed.
NCT07447206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07447206 about?
NCT07447206 is a clinical study titled "Vascular Intervention Strategies Trial for Alzheimer's". The proposed pharmacist-led study is a feasibility pilot trial for the management of vascular risk factors of hypertension and hypercholesterolemia in 10 APOE ε4 carriers, 50-75, at-risk for dementia. All participants will receive angiotensin receptor blockers (ARBs) for high blood pressure, and hyd...
What is the current status of trial NCT07447206?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2026-05. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07447206?
The interventions under investigation include: Angiotensin Receptor Blockers (ARBs) (DRUG), Hydrophilic Statins or Non-Statin Alternative (DRUG).
Who is sponsoring clinical trial NCT07447206?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07447206's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia